Manuel Rodrigues

PSL Research University

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

isabelle ray coquard

professor

FRANCE

View details

Frederic Delom

University of Bordeaux

FRANCE

View details

Samar Alsafadi

PSL Research University

FRANCE

View details

Renaud Sabatier

Associate Professor

Aix-Marseille Université Faculté de Medecine

FRANCE

View details

eleonora timperi

Institut Curie

FRANCE

View details

Aart G Jochemsen

Associate Professor/Group leader

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manuel Rodrigues

Research Interests

Explore related searches

Contact this professor

Articles (9)

Que retenir dans la prise en charge des cancers en 2022 ?

Efficacy of chemotherapy according toBRCAstatus in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse

FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma

Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma

Real-world dostarlimab use in advanced/recurrent endometrial cancer in France.

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.

Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.

Circulating tumor DNA as a Prognostic Factor in Patients with Resectable Hepatic Metastases of Uveal Melanoma.

Collaborators (6)

isabelle ray coquard

Frederic Delom

Samar Alsafadi

Renaud Sabatier

eleonora timperi

Aart G Jochemsen

Make your next move.